People | February 23, 2022
Dr Fabrice Egros gets an additional role at Lupin
He will continue to lead business in LATAM and Asia regions in this new role
He will continue to lead business in LATAM and Asia regions in this new role
Galenicum will oversee development, manufacturing and supply, while Lupin will handle regulatory submissions, approvals, and commercialization and distribution of Semaglutide across 23 countries globally
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
This marks Lupin’s first commercial product leveraging PrecisionSphere, a proprietary long-acting injectable (LAI) technology
Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
Lupin and Zentiva sign license and supply agreement for commercializing Certolizumab
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
The portfolio includes branded injectable cephalosporines for infectious diseases
The OPTASE range is a safe, tested and expert recommended 3-step regime to help tackle the cause and symptoms of eye conditions
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
Subscribe To Our Newsletter & Stay Updated
